European authorities are investigating whether popular weight-loss and diabetes drugs including Novo Nordisk A/S’s Wegovy may be linked to complications during anesthesia.
The European Medicines Agency’s safety committee, PRAC, is discussing the potential safety issue during its meeting this week. The probe com